Dr Mara Aspinwall thinks the US could get to 750 million tests per month by April.
https://www.nationalgeographic.com/science/20...tive-case/
But this would only occur if more manufacturers get their tests authorized for use by the Food and Drug Administration, says Aspinall, professor of practice of biomedical diagnostics at Arizona State University,.
Mara Aspinall, who collaborates with the Rockefeller Foundation to survey the testing landscape, agrees that availability is improving but says it is only barely adequate currently. Aspinall estimates that, right now, there is capacity for about 250 million coronavirus tests to be completed per month in the U.S.
That could more than triple by April to more than 750 million tests per month, which Aspinall says should be enough for the country to get to a consistent national testing regime. But this would only occur if more manufacturers get their tests authorized for use by the Food and Drug Administration, says Aspinall, professor of practice of biomedical diagnostics at Arizona State University,.
"Adalja hopes some of the $50 billion earmarked for testing will be used on widespread at-home rapid testing. “I think it really needs to become the standard,” he says."
"Aspinall also hopes that the FDA speeds up authorization of more tests and that manufacturers ramp up quickly"
https://www.nationalgeographic.com/science/20...tive-case/
But this would only occur if more manufacturers get their tests authorized for use by the Food and Drug Administration, says Aspinall, professor of practice of biomedical diagnostics at Arizona State University,.
Mara Aspinall, who collaborates with the Rockefeller Foundation to survey the testing landscape, agrees that availability is improving but says it is only barely adequate currently. Aspinall estimates that, right now, there is capacity for about 250 million coronavirus tests to be completed per month in the U.S.
That could more than triple by April to more than 750 million tests per month, which Aspinall says should be enough for the country to get to a consistent national testing regime. But this would only occur if more manufacturers get their tests authorized for use by the Food and Drug Administration, says Aspinall, professor of practice of biomedical diagnostics at Arizona State University,.
"Adalja hopes some of the $50 billion earmarked for testing will be used on widespread at-home rapid testing. “I think it really needs to become the standard,” he says."
"Aspinall also hopes that the FDA speeds up authorization of more tests and that manufacturers ramp up quickly"
1
